56 related articles for article (PubMed ID: 38265241)
1. Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
Manning JE; Harris E; Mathieson H; Sorensen L; Luqmani R; McGettrick HM; Morgan AW; Young SP; Mackie SL
J Autoimmun; 2024 May; 147():103260. PubMed ID: 38797046
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging in polymyalgia rheumatica-contrast enhancement is not always needed.
Fruth M; Seggewiss A; Kozik J; Martin-Seidel P; Baraliakos X; Braun J
Z Rheumatol; 2024 May; 83(4):269-276. PubMed ID: 37566119
[TBL] [Abstract][Full Text] [Related]
3. MRI of shoulder girdle in polymyalgia rheumatica: inflammatory findings and their diagnostic value.
Fruth M; Künitz L; Martin-Seidel P; Tsiami S; Baraliakos X
RMD Open; 2024 May; 10(2):. PubMed ID: 38724260
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound intima-media thickness cut-off values for the diagnosis of giant cell arteritis using a dual clinical and MRI reference standard and cardiovascular risk stratification.
Seitz P; Lötscher F; Bucher S; Bütikofer L; Maurer B; Hakim A; Seitz L
Front Med (Lausanne); 2024; 11():1389655. PubMed ID: 38654833
[TBL] [Abstract][Full Text] [Related]
5. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
6. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
Esen I; Arends S; Dalsgaard Nielsen B; Therkildsen P; Hansen I; van 't Ende A; Heeringa P; Boots A; Hauge E; Brouwer E; van Sleen Y
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36631159
[TBL] [Abstract][Full Text] [Related]
7. Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.
van der Geest KSM; Sandovici M; Nienhuis PH; Slart RHJA; Heeringa P; Brouwer E; Jiemy WF
Front Med (Lausanne); 2022; 9():902155. PubMed ID: 35733858
[TBL] [Abstract][Full Text] [Related]
8. Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica.
Seitz P; Cullmann J; Bucher S; Bütikofer L; Reichenbach S; Lötscher F; Amsler J; Christ L; Bonel HM; Villiger PM; Seitz L
Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38265241
[TBL] [Abstract][Full Text] [Related]
9. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
10. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
Schmidt J; Warrington KJ
Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
